Trade REVB anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Revelation Biosciences, Inc. (REVB) is trading at US$1.05, up 1.46% today as of Aug 28, 09:34 EDT. The company has a market capitalisation of US$4.34M. Over the past 52 weeks, REVB has traded between US$0.88 and US$11.60. On Syfe you can trade REVB with $0 commission and add it to your watchlist.
| Previous close | US$1.03 |
|---|---|
| Market cap | US$4.34M |
| 52-week range | US$0.88 – US$11.60 |
| Volume | 19.95K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Revelation Biosciences, Inc.
Revelation Biosciences, Inc. engages in the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.
Year: 2022
Revelation Biosciences Adopts Stockholder Rights Plan
Jul 10, 8:39 PM · MT Newswires
Revelation Biosciences, Inc. (REVB) stock is trading at US$1.05, +1.46% from the previous close of US$1.03.
The market cap for Revelation Biosciences, Inc. (REVB) stock is approximately US$4.34M.
The 52-week high for Revelation Biosciences, Inc. (REVB) stock is US$11.60.
The 52-week low for Revelation Biosciences, Inc. (REVB) stock is US$0.88.
Revelation Biosciences, Inc. (REVB) does not currently pay a dividend.
Stay on top of REVB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
